Skip to content

13F-HR filed by MPM BIOIMPACT LLC

MPM BIOIMPACT LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:06:03 UTC, with 37 holding rows worth $1,347,705,655.

Accession
0001193125-26-463462
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 37 entries on the cover page, a total value of $1,347,705,655 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,347,705,655 with VALUE read as dollars as filed, 13F file number 028-20107. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CULLINAN THERAPEUTICS INC230031106COM9,721,081$149,218,593dollars as filed
AKTIS ONCOLOGY INC01021M104COMMON STOCK4,835,872$94,154,428dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM1,088,363$64,082,813dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM1,575,987$63,985,072dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock3,208,146$51,683,232dollars as filed
CORCEPT THERAPEUTICS INC218352102COM422,000$48,627,060dollars as filed
CORCEPT THERAPEUTICS INC218352102COM422,000$48,627,060dollars as filedput
RELAY THERAPEUTICS INC COM75943R102Stock2,369,578$42,770,883dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock2,978,906$42,657,934dollars as filed
IOVANCE BIOTHERAPEUTICS INC462260100COM2,835,734$42,025,578dollars as filed
LIQUIDIA CORPORATION COM NEW53635D202Stock1,342,713$40,630,495dollars as filed
NATERA INC COM632307104Stock90,585$37,439,686dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK909,691$36,960,745dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR1,203,289$36,447,624dollars as filed
DBV TECHNOLOGIES S A23306J309SPONSORED ADS3,044,659$35,805,190dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK7,262,959$35,370,610dollars as filed
ABIVAX SA-00370M103SPONSORED ADS328,379$32,516,089dollars as filed
VIR BIOTECHNOLOGY INC92764N102COM2,809,711$31,412,569dollars as filed
Adlai Nortye00704R109SPONSORED ADS1,956,618$31,305,888dollars as filed
VERASTEM INC92337C203COMMON STOCK3,851,604$31,005,412dollars as filed
UNIQURE NVN90064101SHS1,201,413$29,026,138dollars as filed
Odyssey Therapeutics, Inc.67613T104COMMON STOCK1,289,091$28,643,602dollars as filed
TARSUS PHARMACEUTICALS INC87650L103COMMON STOCK352,676$27,723,860dollars as filed
PALVELLA THERAPEUTICS INC697947109COMMON STOCK197,633$27,259,520dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock5,178,127$27,236,948dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock300,000$24,987,000dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM1,821,951$24,541,680dollars as filed
STOKE THERAPEUTICS INC86150R107COM925,133$24,053,458dollars as filed
BELITE BIO INC07782B104CMN133,387$22,651,780dollars as filed
NEUROGENE INC64135M105COMMON STOCK771,839$21,472,561dollars as filed
ZURA BIO LTDG9TY5A101COMMON STOCK4,449,671$18,510,631dollars as filed
ANNEXON INC03589W102COM4,290,616$18,149,306dollars as filed
MONTE ROSA THERAPEUTICS INC61225M102COM1,125,216$13,423,827dollars as filed
BIOAGE LABS INC COM09077V100Stock1,856,748$13,164,343dollars as filed
CORBUS PHARMACEUTICALS21833P301COM NEW1,667,272$11,370,795dollars as filed
BRIGHT MINDS BIOSCIENCES INC10919W405COMMON STOCK195,669$9,748,230dollars as filed
FIRST TRACKS BIOTHERAPEUTICS337185102ORD SHS *A*254,374$9,015,015dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001193125-26-463462this filing2026-11-16